PBFDX
Price
$32.31
Change
+$0.28 (+0.87%)
Updated
Jun 6 closing price
Net Assets
296.71M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

PBFDX vs VITSX

Header iconPBFDX vs VITSX Comparison
Open Charts PBFDX vs VITSXBanner chart's image
Payson Total Return
Price$32.31
Change+$0.28 (+0.87%)
VolumeN/A
Net Assets296.71M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
PBFDX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PBFDX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBFDX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. PBFDX (297M). VITSX pays higher dividends than PBFDX: VITSX (1.29) vs PBFDX (0.29). PBFDX was incepted earlier than VITSX: PBFDX (34 years) vs VITSX (28 years). PBFDX (0.81) is less costly to investors than VITSX (0.03). PBFDX is a more actively managed with annual turnover of: 65.00 vs. VITSX (2.00). PBFDX has a lower initial minimum investment than VITSX: PBFDX (2000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. PBFDX (0.98). VITSX return over 5 years is better than : 80.96 vs. PBFDX (44.91).
PBFDXVITSXPBFDX / VITSX
Total Expense Ratio0.810.032,700%
Annual Report Gross Expense Ratio0.810.032,700%
Fund Existence34 years28 years-
Gain YTD2.1680.833260%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets297M1.82T0%
Annual Yield % from dividends0.291.2923%
Returns for 1 year0.9810.979%
Returns for 3 years25.8440.3564%
Returns for 5 years44.9180.9655%
Returns for 10 years124.71180.4969%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.